Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) Vasopressin Antibodies:
anti-Human Vasopressin Antibodies:
anti-Mouse (Murine) Vasopressin Antibodies:
Go to our pre-filtered search.
Chicken Polyclonal Vasopressin Primary Antibody for IEM, ICC - ABIN617884
Fleming, Dallemagne, Endre, Yesberg, Cross: Acute lowering of plasma oncotic pressure increases filtration fraction and sodium excretion in conscious sheep. in Renal physiology and biochemistry 1993
Show all 110 Pubmed References
Human Monoclonal Vasopressin Primary Antibody for IF, IHC (p) - ABIN109870
Blume, Torner, Liu, Subburaju, Aguilera, Neumann: Prolactin activates MAP kinase signaling and corticotropin releasing hormone (CRH) transcription in rat hypothalamic neurons. in Endocrinology 2008
Show all 2 Pubmed References
Human Polyclonal Vasopressin Primary Antibody for ICC, IHC - ABIN286067
Aujla, Bora, Monahan, Sweedler, Raetzman: The Notch effector gene Hes1 regulates migration of hypothalamic neurons, neuropeptide content and axon targeting to the pituitary. in Developmental biology 2011
three Arabidopsis ADH conformations and the complex crystal that was with NAD
High circulating copeptin and decline in glomerular filtration rate indicate greater risk of new onset chronic kidney disease. (Review)
MR-proADM but not copeptin was significantly associated with prognosis of COPD (show ARCN1 Antibodies) exacerbations at 30 days.
vasopressin and the glycopeptide - mediate physiological aggregation of the wild-type hormone precursor into secretory granules and the pathological fibrillar aggregation of disease mutants in the endoplasmic reticulum.
The inability to clear misfolded proAVP with highly reactive cysteine thiols in the absence of Sel1L (show SEL1L Antibodies)-Hrd1 (show SYVN1 Antibodies) ERAD causes proAVP to accumulate and participate in inappropriate intermolecular disulfide-bonded aggregates, promoted by the enzymatic activity of protein disulfide isomerase (PDI (show P4HB Antibodies)).
High copeptin expression is associated with hypoxic-ischemic encephalopathy.
Copeptin and osmolality were unaffected by sitagliptin treatment in type 2 diabetics with acute coronary syndrome.
Copeptin levels are highest among acute myocardial infarction patients with glucose disturbances and predict an adverse prognosis in unadjusted analyses.
high serum copeptin level is associated with disease severity and progression in IgA nephropathy.
Copeptin was independently associated with an increased risk of incident stroke and CVD mortality in men with diabetes, but not in men without diabetes.
Copeptin level at admission predicts final infarct size in STEMI patients.
PDZ domain-containing protein (show USH1C Antibodies) Sipa1l1 (signal-induced proliferation-associated 1 like 1 (show SIPA1L1 Antibodies)) binds to the cytoplasmic PDZ (show INADL Antibodies)-ligand motif of aquaporin-2 (show AQP2 Antibodies) and accelerates its endocytosis in the absence of vasopressin
Spatiotemporal profiles of arginine vasopressin (AVP) expression at the pixel level revealed circadian rhythms in the entire area of AVP-positive cells in the suprachiasmatic nucleus, and at least two clusters that showed different circadian oscillations.
Results suggest morphological and functional differences among the paraventricular nucleus' subnuclei and complex interactions among Chronic Unpredictable Stress, gonadal hormones and AVP immunoreactivity
Autophagy was induced in the AVP neurons subjected to endoplasmic reticulum stress in familial neurohypophysial diabetes insipidus mice.
A new role of PcG proteins in priming early-life stress-responsive DNA methylation (show HELLS Antibodies) at the Avp enhancer prior to epigenetic programming.
The noradrenaline-nitric oxide pathway, which stimulates the expression of vasopressin, involves free radicals.
AVP, via activation of V1 receptors, is able to modulate positively contractile activity of longitudinal muscle of mouse distal colon.
Dehydration increased plasma osmolality and vasopressin levels, and suppressed the increase in blood flow induced by neural activity, by the endothelium-dependent vasodilator acetylcholine and the smooth muscle relaxant adenosine.
Vasopressin expression in the suprachiasmatic nucleus is independent of Crx (cone-rod homeobox (show CRX Antibodies))-regulated photoreceptor systems.
This suggests that increased IL-1beta (show IL1B Antibodies) and NO levels may cause significant bioenergetics changes in magnocellular neurons, affecting copeptin expression and compromising AVP synthesis and secretion in the late phase of sepsis.
Atrial natriuretic peptide (show NPPA Antibodies) and vasopressin-presence in the ciliary body of eye in the pig (sus domesticus).
This gene encodes a precursor protein consisting of arginine vasopressin and two associated proteins, neurophysin 2 and a glycopeptide, copeptin. Arginine vasopressin is a posterior pituitary hormone which is synthesized in the supraoptic nucleus and paraventricular nucleus of the hypothalamus. Along with its carrier protein, neurophysin 2, it is packaged into neurosecretory vesicles and transported axonally to the nerve endings in the neurohypophysis where it is either stored or secreted into the bloodstream. The precursor is thought to be activated while it is being transported along the axon to the posterior pituitary. Arginine vasopressin acts as a growth factor by enhancing pH regulation through acid-base transport systems. It has a direct antidiuretic action on the kidney, and also causes vasoconstriction of the peripheral vessels. This hormone can contract smooth muscle during parturition and lactation. It is also involved in cognition, tolerance, adaptation and complex sexual and maternal behaviour, as well as in the regulation of water excretion and cardiovascular functions. Mutations in this gene cause autosomal dominant neurohypophyseal diabetes insipidus (ADNDI).
arginine vasopressin (neurophysin II, antidiuretic hormone, diabetes insipidus, neurohypophyseal)
, arginine vasopressin-neurophysin II
, arginine vasopressin
, neurophysin 2
, arginine vasopressin (neurophysin 2, antidiuretic hormone, diabetes insipidus, neurohypophyseal)
, alcohol dehydrogenase (class I), alpha polypeptide
, alcohol dehydrogenase 1
, alcohol dehydrogenase 1, complex
, alcohol dehydrogenase 1C (class I), gamma polypeptide
, alcohol dehydrogenase A subunit
, antidiuretic hormone
, prepro-AVP-NP II
, prepro-arginine-vasopressin-neurophysin II
, vasopressin-neurophysin 2-copeptin
, vasopressin-neurophysin II-copeptin
, arginine vasopressin (Diabetes insipidus), same as Di (conflicting physical mapping)
, vasopressin-neurophysin prepropeptide
, neurophysin II